Lower-risk Myelodysplastic Syndromes: Data Updates and Evolving Treatment Paradigms in the Frontline Setting - Episode 1

Risk Stratification of Myelodysplastic Syndromes [MDS]

,

Ralph Boccia, MD, FACP, and Hetty Carraway, MD, review Myelodysplastic Syndromes [MDS] risk stratification criteria used in their practices.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    Now Viewing
    EP. 1: Risk Stratification of Myelodysplastic Syndromes [MDS]
    EP. 2: Importance of Early Diagnosis of MDS for Lower and Higher-risk Patients
    EP. 3: Frontline Treatment Options for Lower-Risk MDS
    EP. 4: Clinical Use of Luspatercept on Patients with Lower-risk MDS
    EP. 5: Safety and Efficacy of Luspatercept in Frontline Setting in Patients with MDS
    EP. 6: Emerging Therapies for Treatment of MDS
    EP. 7: Clinical Management of Patients with Lower-risk MDS
    EP. 8: Unmet Needs and Future Perspectives in Treatment of MDS
    x